Approved medicines Human studies in product label Hormone research
Also discussed as: DDAVP, desmopressin acetate
What it is and how it works
Desmopressin is an analogue of vasopressin with antidiuretic activity, helping the kidneys retain water. The same physiological action that supports a labeled use can also create risk from excess water retention and low sodium.
Source for the mechanism context →A closer look at the cited evidence
Human studies in product label
This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.
- Study or assessment
- DailyMed — DDAVP Tablets labeling and clinical evidence
- Design
- Tablet prescribing information describing clinical effects and defined indications.
- Who or what was studied
- Patients within the central diabetes insipidus and primary nocturnal enuresis label criteria.
- What was observed
- The medicine’s antidiuretic effect underlies these specific uses.
- Limits of interpretation
- Other desmopressin formulations have different indications and warnings. This profile cannot supply instructions for fluid management or treatment.
What the evidence means
The tablet label addresses central diabetes insipidus and primary nocturnal enuresis; other formulations have different uses.
Approval and regulatory context
DDAVP Tablets have defined approved indications. A brand or molecule name alone does not identify the appropriate product.
Safety and uncertainty
Water retention can lead to dangerously low blood sodium. Kidney function, interacting medicines, and formulation-specific warnings matter.
What remains uncertain
The exact product and diagnosis are essential. An educational explanation of water handling cannot determine an individual’s sodium risk or replace the medical assessment and monitoring associated with this medicine.
These summaries are introductory and are not a complete account of the literature, adverse effects, contraindications, or interactions. Absence of a listed risk does not mean absence of risk. Different compounds, formulations, and routes cannot be treated as interchangeable.
Sources behind this overview
Read the source in its full context. Source links support the overview; they do not imply endorsement of this library by the source organization.